Previous Article | Next Article 
Journal of Virology, December 2004, p. 12829-12837, Vol. 78, No. 23
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.23.12829-12837.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Identification of Cellular Cofactors for Human Immunodeficiency Virus Replication via a Ribozyme-Based Genomics Approach
Shani Waninger,1
Kelli Kuhen,2
Xiuyuan Hu,1
Jon E. Chatterton,1
Flossie Wong-Staal,1,2 and
Hengli Tang1,2*
Immusol Inc., San Diego,1
Department of Biology and Medicine, University of California San Diego, La Jolla, California2
Received 22 April 2004/
Accepted 22 July 2004
Ribozymes are small, catalytic RNA molecules that can be engineered to down-regulate gene expression by cleaving specific mRNA. Here we report the selection of hairpin ribozymes that inhibit human immunodeficiency virus (HIV) replication from a combinatorial ribozyme library. We identified a total of 17 effective ribozymes, each capable of inhibiting HIV infection of human CD4+ cells. These ribozymes target diverse steps of the viral replication cycle, ranging from entry to transcription. One ribozyme suppressed HIV integration and transcription by inhibiting the expression of the Ku80 subunit of the DNA-activated protein kinase. Another ribozyme specifically inhibited long terminal repeat transactivation, while two additional ones blocked a step that can be bypassed by vesicular stomatitis virus G-protein pseudotyping. The function of Ku80 in HIV replication and its mechanism of action were further confirmed using short interfering RNA. Identification of the gene targets of these and other selected ribozymes may reveal novel therapeutic targets for combating HIV infection.
* Corresponding author. Present address: Department of Biological Sciences, Biology Unit 1, Florida State University, Tallahassee, FL 32306-4370. Phone: (850) 645-2402. Fax: (850) 644-0481. E-mail:
tang{at}bio.fsu.edu.
Journal of Virology, December 2004, p. 12829-12837, Vol. 78, No. 23
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.23.12829-12837.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Kenworthy, R., Lambert, D., Yang, F., Wang, N., Chen, Z., Zhu, H., Zhu, F., Liu, C., Li, K., Tang, H.
(2009). Short-hairpin RNAs delivered by lentiviral vector transduction trigger RIG-I-mediated IFN activation. Nucleic Acids Res
37: 6587-6599
[Abstract]
[Full Text]
-
Qing, M., Yang, F., Zhang, B., Zou, G., Robida, J. M., Yuan, Z., Tang, H., Shi, P.-Y.
(2009). Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein. Antimicrob. Agents Chemother.
53: 3226-3235
[Abstract]
[Full Text]
-
Yang, F., Robotham, J. M., Nelson, H. B., Irsigler, A., Kenworthy, R., Tang, H.
(2008). Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro. J. Virol.
82: 5269-5278
[Abstract]
[Full Text]
-
Robida, J. M., Nelson, H. B., Liu, Z., Tang, H.
(2007). Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro. J. Virol.
81: 5829-5840
[Abstract]
[Full Text]
-
Shi, L., Qiu, D., Zhao, G., Corthesy, B., Lees-Miller, S., Reeves, W. H., Kao, P. N.
(2007). Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cells. Nucleic Acids Res
35: 2302-2310
[Abstract]
[Full Text]
-
Eberhardy, S. R., Goncalves, J., Coelho, S., Segal, D. J., Berkhout, B., Barbas, C. F. III
(2006). Inhibition of Human Immunodeficiency Virus Type 1 Replication with Artificial Transcription Factors Targeting the Highly Conserved Primer-Binding Site. J. Virol.
80: 2873-2883
[Abstract]
[Full Text]
-
Nelson, H. B., Tang, H.
(2006). Effect of Cell Growth on Hepatitis C Virus (HCV) Replication and a Mechanism of Cell Confluence-Based Inhibition of HCV RNA and Protein Expression. J. Virol.
80: 1181-1190
[Abstract]
[Full Text]
-
Nguyen, D. G., Wolff, K. C., Yin, H., Caldwell, J. S., Kuhen, K. L.
(2006). "UnPAKing" Human Immunodeficiency Virus (HIV) Replication: Using Small Interfering RNA Screening To Identify Novel Cofactors and Elucidate the Role of Group I PAKs in HIV Infection. J. Virol.
80: 130-137
[Abstract]
[Full Text]